News and Announcements
The Investor Turn-Off: Avoid This Common Blunder in Your Pitch
- Published September 19, 2023 11:00PM UTC
- Publisher Wholesale Investor
- Categories Capital Raising Tips
Every founder dreams of securing that game-changing investment to propel their startup to new heights. However, in the quest to impress investors, many unknowingly commit a cardinal sin that can instantly dampen investor interest.
In this video, Steve Torso sheds light on a prevalent and frustrating habit that founders often fall prey to: comparing their startups to industry giants like Airbnb, Uber, or Facebook. While the intention might be to convey potential and ambition, this approach can backfire spectacularly.
Why Comparisons Don’t Work:
- Irrelevance: Drawing parallels to multi-billion-dollar businesses can come across as irrelevant, especially if your business model or industry doesn’t align with the giants you’re referencing.
- Lack of Originality: Investors are on the lookout for unique and innovative solutions. By likening your startup to well-established companies, you risk appearing unoriginal or even lazy in your pitch.
- Miscommunication: The goal is to articulate your business model and value proposition clearly. Using comparisons can muddle your message and leave investors confused about what you truly offer.
Crafting a Compelling Pitch: Instead of leaning on comparisons, focus on your unique selling proposition (USP). What sets your startup apart? Why should investors be excited about your venture? By honing in on your USP and communicating it effectively, you stand a better chance of capturing an investor’s attention and, more importantly, their trust.
In conclusion, while the allure of drawing parallels to industry giants can be tempting, it’s essential to remember that investors are looking for the next big thing, not a replica of what already exists.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
